Toyonaka, Japan

Masatomo Nojima

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masatomo Nojima. Retrieved from https://idiyas.com/inventor/masatomo-nojima-plcfe9gs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masatomo Nojima: Innovator in Ozonide Compounds

Introduction

Masatomo Nojima is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of ozonide compounds. His work focuses on compounds that exhibit inhibitory activity for urokinase production and angiogenesis.

Latest Patents

Masatomo Nojima holds 1 patent for his innovative work on ozonide compounds. This patent addresses important therapeutic applications, potentially impacting treatments related to angiogenesis and related diseases.

Career Highlights

Nojima is currently employed at Taiho Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His expertise in medicinal chemistry has positioned him as a valuable asset within the pharmaceutical industry.

Collaborations

One of his notable collaborators is Takuma Sasaki, with whom he has worked closely on various projects. Their combined efforts have contributed to the advancement of their research initiatives.

Conclusion

Masatomo Nojima's innovative work in ozonide compounds highlights his significant role in the pharmaceutical field. His contributions are paving the way for new therapeutic options and advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…